Adding Lurbinectedin to First-Line Atezolizumab Maintenance Treatment Prolongs Survival Over Atezolizumab Alone in Patients with ES-SCLC By Ogkologos - July 14, 2025 513 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the IMforte study Source RELATED ARTICLESMORE FROM AUTHOR Adding Epcoritamab to Lenalidomide and Rituximab Results in Higher Response Rate and Longer PFS in Patients with Relapsed or Refractory Follicular Lymphoma Patient Guide in Prostate Cancer Now Available in Vietnamese One Dose of Either a Bivalent or Nonavalent HPV Vaccine Provides Protection Against HPV16 or HPV18 Infection and Is Not Inferior To Two Doses MOST POPULAR FDA Approves Nivolumab Plus Cabozantinib for Advanced Renal Cell Carcinoma January 25, 2021 5-Year-Old Boy Meets Generous Stem Cell Donor Who Cured Him October 13, 2021 Sister Is There To Comfort Her Little Brother As He Battles... September 10, 2019 The Galleri multi-cancer blood test: what you need to know September 13, 2021 Load more HOT NEWS Educators Raise Money in Memory of Teacher Who Dedicated Herself to... Adjusting to the Challenges of Life After Cancer: An Expert Perspective Four randomized prospective degree compared 90 days regarding neoadjuvant ADT observed... Expanding Research on Dormant Cancer Cells Aims to Prevent Metastasis
